XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series A-2 Preferred Stock
Series D Preferred Stock
Preferred Stock
Series A-2 Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Preferred Stock
Series D Preferred Stock
Preferred Stock
Series E Preferred Stock
Common Stock
Common Stock
Series C Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2018       32 75 525 0 0 5,114,000   133,000    
Beginning Balance at Dec. 31, 2018 $ 6,830     $ 0 $ 0 $ 0 $ 0 $ 0 $ 1   $ (496) $ 184,998 $ (177,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (7,761)                       (7,761)
Stock-based compensation 110                   $ (51) 110  
Issuance of preferred stock in merger (in shares)             1,736,626            
Issuance of preferred stock in merger $ 18,862                     18,862  
Forfeiture of preferred stock (in shares) (10,063)           (1,725)            
Preferred stock conversion (in shares)         75 50     43,919 16,667      
Preferred stock dividends $ 27                     27  
Issuance of stock on vested restricted stock units (in shares)                 109,000   (76,000)    
Issuance of stock on vested restricted stock units 0                   $ 382 (382)  
Proceeds from Series E equity offering (in shares)               131,579          
Proceeds from Series E equity offering 3,750                     3,750  
Series D exchanged for taxes (in shares)                     (48,000)    
Preferred stock dividends (27)                     (27)  
Forfeiture of restricted stock agreement (in shares)                 0        
Repurchase of treasury stock (in shares)                     48,000    
Repurchase of treasury stock (51)                   $ (51)    
Issuance of warrants to purchase common stock in connection with long term debt 72                     72  
Ending Balance (in shares) at Dec. 31, 2019       32 0 475 1,734,901 131,579 5,267,000   105,000    
Ending Balance at Dec. 31, 2019 21,785     $ 0 $ 0 $ 0 $ 0 $ 0 $ 1   $ (165) 207,383 (185,434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (7,421)                       (7,421)
Stock-based compensation (in shares)                 8,000        
Stock-based compensation 198                   $ (16) 198  
Issuance of preferred stock for accrued dividends (in shares)       13                  
Issuance of preferred stock for accrued dividends 99                     99  
Forfeiture of preferred stock (in shares)             (28,618)            
Preferred stock conversion (in shares)   13 1,686,659     475     158,333 158,333      
Preferred stock dividends 17                     17  
Issuance of stock on vested restricted stock units (in shares)                 23,000   8,000    
Issuance of stock on vested restricted stock units (16)                   $ (16)    
Series D exchanged for taxes (in shares)             (8,325)       (8,000)    
Preferred stock dividends (17)                     (17)  
Forfeiture of restricted stock agreement (in shares)                 (9,321)        
Issuance of common shares from financing, net of offering costs (in shares)                 2,293,000        
Issuance of common shares from financing, net of offering costs 7,371                     7,371  
Issuance of common shares from warrant exercise (in shares)                 72,000        
Issuance of warrants to purchase common stock in connection with long term debt                       72  
Issuance of shares for professional service fees (in shares)                 50,000        
Issuance of shares for professional service fees 58                     58  
Ending Balance (in shares) at Dec. 31, 2020       45 0 0 1,697,958 131,579 7,862,000   113,000    
Ending Balance at Dec. 31, 2020 $ 22,057     $ 0 $ 0 $ 0 $ 0 $ 0 $ 1   $ (181) $ 215,092 $ (192,855)